Resources

Get helpful information about MRD and M-inSight®

All
Articles
Documentation
Events
Posters
Publications
decoration
Posters
12/20/2023

Monitoring of Systemic Light-Chain Amyloidosis patients using Mass Spectrometry (M-inSight) in serum - ASH 2023

Posters
12/20/2023

Multiple Myeloma MRD tracking in blood using ultra sensitive Mass Spectrometry (M-inSight) - ASH 2023

Posters
10/05/2023

Personalized mass spectrometry as a tool for minimal residual disease detection in the blood of myeloma patients - IMS 2023

Publications
08/28/2023

Development of a Targeted MS Serum Assay To Quantify M‑Protein in the Presence of Therapeutic Monoclonal Antibodies - J Proteome Res. 2018

Publications
06/29/2023

MRD Monitoring by Targeted Mass Spectrometry Allows Early Relapse Detection in MM - Blood 2022

Posters
06/29/2023

An ultra-sensitive method for sequencing and monitoring M-protein in peripheral blood - EMN 2023

Publications
06/29/2023

Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for MRD Monitoring in MM - Clin Chem. 2021

Publications
06/29/2023

Mass Spectrometry for Identification, Monitoring, and MRD Detection of M-Proteins - Clin Chem. 2020

Publications
06/29/2023

Multiple Myeloma MRD Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow - Clin Chem. 2021

Publications
06/29/2023

Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry - Blood Cancer J. 2023

ABOUT M-inSight®

Ultra sensitive, Personalized MRD testing in Blood

See what others can't